Arkolith/Insider Trading/OMGA/Form 4

Karande Mahesh

President and CEO, DirectorOmega Therapeutics, Inc. (OMGA) · full profile →Form 4 · filed Feb 3, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2022Option exercise(M)11K$0.53$6K118K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 1, 2022Option exercise(M)11K—$0884K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-004562) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML